Group items tagged

Pompe disease or likewise alluded to as Glycogen stockpiling sickness type II is an autosomal latent metabolic problem that harms nerve cells and muscles all through the body. It is commonly caused because of the amassing of glycogen in the lysosome, attributable to lack of the lysosomal corrosive alpha-glucosidase protein.

The main driving forces propelling the demand for walking assist devices are the surging demand for therapeutic rehabilitation equipment, the ever-increasing incidences of arthritis and rheumatism, and the steadily increasing aging population.

Glycosylated peptide (or glycopeptides) is a new class of drugs used against several disease due to its features, such as low toxicity, target specificity, high activity, and minimal non-specific or drug-drug interactions.